Introduction
should be regulated to occur only when needed, ie in Pathogenicity of HIV-1 in vivo appears to be directly infected cells, in order to minimize unintended siderelated to viral expression levels.
1 Although drugs such effects. as reverse transcriptase (RT) and protease inhibitors have
We have developed a vector-antiviral gene system been shown to be effective over the short term, the which attempts to take all these problems into account. emergence of resistance and side-effects make their longOne construct contains a trans-dominant negative gag term use problematic. For these reasons, several gene mutant, delta-gag, which has been shown to inhibit HIV-1 therapy approaches to prevent or interfere with viral repreplication, possibly by interfering with viral assembly. [4] [5] [6] lication at different stages of HIV-1 life cycle have been Another construct contains both delta-gag and a gene attempted. Antisense oligonucleotides, ribozymes, transencoding eosinophil-derived neurotoxin (EDN), a memdominant negative mutants of HIV-1 gene products, ber of the ribonuclease A superfamily, which is relatively inducible suicide genes, intracellularly expressed antiunselective from the standpoint of its RNA substrate. 7, 8 bodies against viral proteins and molecular decoys for The protective genes are expressed from a dicistronic the Tat-inducible response region (TAR) and Rev responmRNA and the translation of both coding sequences is sive elements (RRE) have been used independently or in ensured by an internal ribosome binding site (IRES) combination to inhibit HIV-1 replication.
2,3 Several facbetween the two coding regions. The constructs use the tors have mitigated against the success of these HIV-1 LTR as a promoter and contain splice donor and approaches. One is the narrow specificity of the antiviral acceptor sites as well as a Rev responsive element (RRE) molecules, combined with the genetic plasticity of HIV-1. so that expression is regulated both by Tat, at the level This could potentially result in the generation of resistant of the RNA synthesis, and Rev, at the level of RNA splicvariants, similar to the situation with drugs. A second ing and transport. Finally, the constructs contain the problem is loss of expression, which can occur with antifunctional HIV-1 primer binding site and packaging sigviral proteins because of immune responses against them. nal, [9] [10] [11] potentially allowing their transmission to HIV-1 Loss of expression can also occur with polymeric TAR target cells. We report here on the effects of these conand RRE molecules by deletion through recombination.
structs on HIV-1 replication in vitro.
regulatory HIV-1 proteins Tat and Rev were included in splicing between the major splice donor site 5′ of gag and a splice acceptor site located in the 3′ LTR of pBAR and the vectors pBAR and pBAR-EDN (Figure 1 ) in order to obtain tightly regulated inducibility (detailed in Materials pBAR-EDN. 14 Under these conditions the full-length RNA remained undetectable, indicating that, in the and methods). To test the regulatory role of Tat and Rev on the expression of vectors pBAR, pBAR-EDN and the absence of Tat and Rev, all the transcripts deriving from the basal activity of HIV-1 LTR were processed to a control plasmid pRBK, each construct was transfected into HeLa cells either alone or in combination with vecmature form which did not contain any of the protective genes. Therefore, this processing mechanism prevented tors expressing Tat and Rev under the control of the RSV promoter. Thirty-six hours following the transfection, the production of the protective proteins in the absence of HIV-1 infection. However, when Tat and Rev were RNA was isolated and Northern analysis performed using HIV-1 LTR as a probe to determine the expression provided in trans by cotransfection along with each construct, the RNA corresponding to the complete size of the levels of the different constructs (Figure 2, top panels) . In the absence of Tat and Rev, low steady-state levels of a transcriptional unit of each plasmid were readily detected at abundant levels, while the 0.8 kb band, corre-0.8 kb RNA were detected, indicating a basal transcriptional activity independent of Tat and Rev (Figure 2 , top sponding to the spliced RNA, became undetectable ( Figure 2 , top right panel). These data demonstrated that left panel). The basal activity is driven by the low constitutive activity of the HIV-1 LTR as previously Tat and Rev activate transcription and allow expression of the full-length RNA. HeLa cells transfected with pRBK reported. 12, 13 As expected, no signal from the control transfection with pRBK was observed. The 0.8 kb RNA plasmid, the negative control, did not show any signal. Consistent with the RNA data, p55 delta-gag protein was represents the fully processed form that originates from detected by both ELISA (not shown) and Western blot luc-LTR-Circle and pGEM-luc plasmids were used as a positive and negative control, respectively. delta-gag were detected after transfection of expressing plasmids, the intracellular levels of luciferase activity were determined (Table 1) . HeLa cells transfected pBAR-EDN compared with pBAR suggesting the possible interference of IRES with the translation of the with pBS-BAR-luc increased luciferase activity 10-fold above the background in the presence of Tat and Rev. upstream gene, as previously described.
Expression of EDN was also analyzed after HeLa transHowever, the magnitude of luciferase activity in cells transfected with pBS-BAR-luc was almost 1000 times less fection with pBAR and pBAR-EDN alone or together with Tat and Rev expressing plasmids. Neither Western than the control plasmid 1LTR-luc-LTR-Circle (Table 1) . Moreover, in HeLa-Tat cells transfected with pBS-BARblot analysis nor enzymatic assays were able to detect any EDN protein in the same cellular extracts where luc the induction of luciferase activity depended on the presence of Rev whereas following transfection with the p55 delta-gag was detected (data not shown). These results were not unexpected. In order to minimize the toxic control 1LTR-luc-LTR-Circle, the reporter gene was constitutively expressed at high levels regardless of Rev. effects due to high levels of EDN expression, 15 the gene was inserted between the IRES and RRE sequences withOverall, these data indicated that the expression of the gene downstream of the IRES sequence was Tat and Rev out the Kozak consensus sequence generally required for optimal translation of eukaryotic mRNAs. 16 The dependent and that its expression was strongly attenuated by the weak activity of the IRES element. These decreased functionality of the IRES sequence was evaluated in transient transfection experiments using the plasresults suggested that the low levels of EDN would likely preclude its detection by conventional methods. mid pBS-BAR-luc, a derivative of pBAR-EDN in which the EDN coding sequence was substituted with the Inhibition of HIV-1 replication in cells expressing the cDNA of the firefly luciferase, whose enzymatic activity protective genes allows the detection of a few molecules per cell (see The protective vectors were inserted into an episomal Materials and methods). The previously described 1LTR-plasmid, pRBK, which serves two purposes: (1) it does not disrupt the configuration of the transfected constructs oratory, NIH, Bethesda, MD, USA) and the HIV-1 NL4-3 molecular clone were also tested under the same experiwhich thus maintain their proper structure (see To explore this possiidentical to those of the control plasmid digested with the same enzyme, indicating that stability and integrity bility we measured the amount of intracellular viral DNA during the course of the infection using a semiquantitof the transfected constructs were not affected by the infection process (data not shown).
ative PCR assay which detected the env region of the HIV-1 ( Figure 4 ). All the infected cultures were positive CEM-RBK, CEM-BAR and CEM-EDN were infected with HIV-1 IIIB at different estimated multiplicities of for HIV-1 at day 1 after infection, indicating that the entry of HIV-1 into the infected cells was similar in all cultures. infection (MOI). Reverse transcriptase (RT) activity and p24 released into the supernatants were measured to Within the first days of infection, CEM-RBK cells became strongly positive for HIV-1 DNA, whereas in CEM-BAR determine the production of HIV-1 over a 60-day period ( Figure 3a) . Infection of the control CEM-RBK cells folcells we measured a delay in the accumulation of HIV-1 DNA, which was more visible at lower MOI, thus conlowed a typical course. Both RT and p24 were readily detected in CEM-RBK supernatants 7 days after infection, firming the results obtained with viral p24 and RT activity in the supernatants (Figure 3a ). More peaking at day 15 and slowly decreasing to reach minimum levels by day 60. This trend remained basically importantly, we observed a dramatic inhibition of HIV-1 DNA production in CEM-EDN cells as compared with unchanged regardless of the MOI of infection. Similarly, the recovery of p24 and RT activity in the supernatant of both CEM-RBK and CEM-BAR cells. This inhibition appeared complete following the infection at lower MOI. the CEM-BAR cells indicated that these cells were productively infected by the HIV-1 IIIB . However, the detecThese results indicated that all the cultures were susceptible to infection with HIV-1, but while CEM-RBK and tion of RT activity and p24 from the supernatant of CEM-BAR was slightly delayed when lower MOI (0.2 and 0.02) CEM-BAR permitted spread of the virus in the culture in a relatively short time, CEM-EDN suppressed the prowere used for infection, indicating that the induction of the delta-gag mutant exerted a partially protective action gression of infection. Extrachromosomal forms of HIV-1 are a measure of in these cells. The absence of a steadily expressed deltagag protein might explain the lack of the stronger protecongoing replication of the virus. 17, 18 In order to distinguish between integrated and extrachromosomal HIVtive capability of the transdominant mutant previously described in other systems. 4 In contrast, infection of 1 viral DNA forms, by semiquantitative PCR we measured the amount of double LTR characteristic of the unin-CEM-EDN was not productive as demonstrated by the complete absence of RT activity and p24 in the supertegrated forms of HIV-1 produced during infection ( 
(a) CEM-RBK (square), CEM-BAR (diamond) or CEM-EDN (circle) were infected with different estimated MOI (2, 0.2, 0.02) of HIV-1 IIIB and cell culture supernatants were assayed for RT activity (upper panels) and p24 production (lower panels) on the indicated days. (b) Time-course analysis of p24 recovery in the supernatants of CEM-RBK, CEM-BAR or CEM-EDN following infection with HIV-1 BZ167 and HIV-1 NL4-3 .
CEM-EDN. It is important to note that HIV-1 replication for a shorter period of time compared with CEM-RBK control cells. This is likely due to the activity of p55 deltawas never completely suppressed in CEM-EDN cells but rather kept under strict control. Cell viability and surface gag produced by the 3.5 kb BAR mRNA detected below the singly spliced 4.0 kb HIV-1 mRNA ( Figure 6 ). In CD4 expression of infected CEM-EDN cells were high (over 90%) during the whole course of infection (not CEM-EDN cells, HIV-1 full-length RNA was detected throughout the time-course of analysis but, most shown).
The transcriptional activation of HIV-1 and protective importantly, the levels of expression were very low compared with both HIV-1 infected CEM-RBK and CEMgenes during the infection period was determined by Northern blot analysis after infection of the transduced BAR cells. This was very likely due to the activity of EDN produced by the 4.0 kb BAR-EDN mRNA which cocells with HIV-1 IIIB at an estimated MOI of 2.0 ( Figure 6 ). The pattern of HIV-1 RNA expression in the infected cells migrated with the singly spliced 4.0 kb HIV-1 mRNA ( Figure 6 and data not shown). Taken together, these data paralleled the recovery of RT activity and p24 in the supernatants. In particular, in infected CEM-BAR cells indicate that EDN, although expressed at low levels, hinders HIV-1 replication. HIV-1 RNA production was slightly delayed and lasted 
Antiviral vector RNA is incorporated into the HIV-1 virion
to rehybridizing the filter with an ampicillin-specific probe, thus ruling out any reactivity from contaminating Although we did not detect any viral release from CEM-EDN cells following infection with HIV-1, the vector was transfected DNA (data not shown). designed to contain the HIV-1 packaging signal. To test whether the RNA transcribed from the protective conDiscussion structs was incorporated into the HIV-1 virions, HeLaTat cells were cotransfected with the pHXB2 infectious
We have shown that a system based on a novel construct in which the expression of genes interfering with HIV-1 molecular clone of HIV-1 along with each of the plasmids. Forty-eight hours after transfection, supernatants replication is tightly and specifically dependent on HIV-1 activation, provides long-term protection in vitro. The were collected and the RNA extracted from the supernatants was analyzed by dot blot. Hybridization was carvector also contains all the structural elements required for self-propagation in the presence of HIV-1, thereby ried out with either a LTR probe, which recognizes both the HIV-1 genomic RNA and the RNA transcribed from potentially endowing neighboring cells with the protective genes. the protective constructs ( Figure 7, left panel) , an IRES probe which detects only pBAR-EDN RNA (Figure 7 ,
Other approaches aimed at interfering with HIV-1 replication were based on HIV-1 Tat or Rev inducible protecmiddle panel) or an ENV probe, which recognizes only HIV-1 genomic RNA ( Figure 7, right panel) . The results tive genes. 5, [19] [20] [21] These systems offer the advantage of not requiring the constitutive expression of the protective demonstrated that both BAR and BAR-EDN genomes were packaged into the HIV-1 virion with an efficiency gene, which may be toxic for the cells in the absence of HIV-1 or elicit an immunological response. On the other comparable to HIV-1 (Figure 7) . No signal was detected
Figure 7 The RNA from the protective vectors is incorporated into HIV-1 virions. Where indicated, pRBK, pBAR or pBAR-EDN were cotransfected (+ sign) into HeLa-Tat cells with a molecular clone of HIV-1 (pHXB2). pHXB2 was cotransfected with each construct at two molar ratios (1:1 and 1:4). Forty-eight hours after the transfections, RNA contained in the supernatant was extracted, digested with RNase-free DNase, and spotted by twofold serial dilutions on to a nylon filter. Hybridization was performed using a LTR probe (left panel), a probe specific for the IRES sequence (middle panel) or a probe specific for ENV (right panel). No signal was detected after rehybridization of the same filters with a probe specific for the ampicillin gene, thus confirming the absence of contaminating plasmid DNA carried over from the transfection (not shown). Rehybridization with DNA (not shown) confirmed that equal amounts of tracer from each sample was loaded (see Materials and methods).

hand, previous data consistently demonstrated the pres-
We have also demonstrated that in vitro the pBAR-EDN RNA is packaged into the HIV-1 virion with an ence of basal levels of activity from the HIV-1 LTR or RRE containing vectors. 12, 13, 22 Therefore, a tighter and efficiency comparable with that of HIV-1, thereby potentially allowing the transmission of the protective genes more specific control of the activity of HIV-1 inducible vectors requires further levels of regulation. In the vecto those cells that may be the target of HIV-1. The use of helper HIV-1-free packaging systems will be required to tors described herein, the expression of the protective gene(s) is subordinated to that of the HIV-1 early regulatexploit completely the antiviral effects of the the BAR-EDN protective vector both in HIV-1 infected and nonory proteins Tat and Rev. The introduction of inhibitory sequences contained in the gag gene of HIV-1 23 and the infected primary cells which are not amenable to efficient transfection. presence of splice donor and acceptor signals in the primary RNA transcript prevent the expression of the proEfforts to develop HIV-1-based constructs have been undertaken in different laboratories because of the potentective gene(s) in the absence of HIV-1.
Using this system, we analyzed the protective efficacy tial for the treatment of acquired immunodeficiency syndrome. [24] [25] [26] The efficacy of Tat inducible protective genes of the negative trans-dominant delta-gag, the antiviral activity of which is exerted at the level of the structural has been recently described in vivo. 27 In these experiments, the life span of ex vivo protected CD4
+ peripheral assembly of HIV-1 virions, alone or in combination with the EDN gene, a human ribonuclease. 8 We have shown blood lymphocytes was increased in vivo, although only for a short period of time. The data demonstrate that this that HIV-1 replication is inhibited in cells stably transfected with the vector containing the combination of approach is feasible and that it may be effective in retarding CD4 + cells' depletion. In addition, HIV-1-based delta-gag and EDN, while in cells expressing delta-gag alone HIV-1 replication is only delayed.
vectors can be transduced into nonreplicating cells in vivo, 28 The BAR-EDN protective system presented herein provides long-term inhibition of HIV-1 replication. Although is constantly produced at low levels and never eliminated from the culture. However, analysis of HIV-1 extrathe elucidation of EDN mechanism of action was not addressed in this article, the specificity of expression of chromosomal DNA after long-term culture of CEM-EDN cells infected with high MOI of HIV-1, indicated the the BAR-EDN construct, its ability to be packaged into virions, its effectiveness against HIV-1 and its apparent occurrence of low levels of HIV-1 replication. In fact, semiquantitative PCR indicated that the number of newly lack of toxic effects on T cells are reasons to believe that this approach might be useful in the therapy of AIDS. Expression vectors Vectors were constructed by insertion of the protective speculate that modulation of HIV-1 replication is due to the reciprocal control of HIV-1 and the protective system. genes into pRBK (Invitrogen, San Diego, CA, USA), an episomal mammalian expression plasmid vector, whose According to this model, the production of Tat and Rev by newly infecting HIV-1 would result in the activation replication is driven by the large T antigen and the origin of replication of BK papovavirus. For the construction of of the protective genes which in turn shut down viral expression. Thus, in the absence of Tat and Rev, the propBAR, the 5′ LTR from HIV-1 molecular clone pLW/C 29 and delta-gag from a plasmid containing a dominant tective system remains silent so that HIV-1 is produced again and the cycle reinitiates. Alternatively, the modunegative gag gene 4 were amplified using the primer pairs SU3/EU5AS and EU5S/XDGAS, respectively, with Vent lation of HIV-1 replication might result from the reduced stability or loss of episomal pRBK-derived constructs in DNA polymerase (New England Biolabs, Beverly, MA, USA) following the manufacturer's instructions. The a few cells over time, thereby allowing the spreading of a small amount of HIV-1. delta-gag gene was provided with two stop codons (see the oligonucleotide sequence) to ensure termination of Importantly, during the time-course of the analysis, viability and surface CD4 expression of CEM-EDN cells transcription. At the junction between the LTR and deltagag an EcoRI site which does not disrupt either the primer was high, as compared with CEM-RBK and CEM-BAR, suggesting that the efficacy of EDN was not attributable binding site or the major splice donor was inserted. After EcoRI digestion, PCR products were ligated together and to its potential toxicity. EDN is a ribonuclease whose catalytic activity appears to be independent of RNA purified on an agarose gel. Following SmaI-XbaI digestion, the LTR-delta-gag fragment was cloned into the structure or sequence. 8 Its use as an antitumor toxin has been previously proposed. 7 Therefore, to prevent cell SmaI-XbaI sites of the Bluescript II SK plasmid (Stratagene, La Jolla, CA, USA). A DNA fragment condeath, our vector was designed to minimize EDN expression. The low levels of activity of the luciferase taining the RRE and 3′ LTR (derived from the HXB2 molecular clone of HIV-1) was amplified from the pCgagA2 gene inserted in place of EDN indicates that this strategy was successful. Although we could not detect EDN proplasmid (kindly provided by B Felber, ABL, Basic Research Program, NCI-FCRDC, Frederick, MD, USA) tein expression, the increased protective effect of the vector containing EDN over that with delta-gag alone as well with Vent DNA polymerase using the primer pair SRRES/BLU5AS and inserted into the XhoI-BamHI sites as the the low functionality of the IRES ( Table 1 ) strongly suggests that EDN protein is indeed expressed.
of the pRBK plasmid. The pRBK containing RRE plasmid 73 was digested with NheI-SacII and the DNA fragment conanalyzed for p55 delta-gag , luciferase activity, RNA or EDN content as indicated. taining the RRE-LTR DNA fragment and the SV40 polyadenylation signal (SV40pA) derived from the pRBK plasmid was subcloned into the XbaI-SacII sites of the RNA extraction and analysis Total cellular RNA was extracted using TRIzol reagent Bluescript plasmid containing the LTR-delta-gag DNA fragment, thus obtaining pBS-BAR. Clone pBS-BAR was (Life Technologies, Gaithersburg, MD, USA) according to the manufacturer's instructions. For Northern blot analydigested with SmaI-SacII and inserted into the MscI-SacII sites of the pRBK plasmid to obtain the pBAR plasmid.
sis, 10 g of RNA were electrophoresed on a formaldehyde denaturing 1.2% agarose gel. After electroFor the construction of pBAR-EDN, the pET/EDN plasmid, 30 containing the coding sequence of EDN and lackphoresis, RNA was transferred on to a Nytran membrane (Schleicher and Schuell, Keene, NH, USA) and UV crossing the amino terminal portion of the protein responsible for its secretion, was digested with XbaI-BamHI and sublinked. Hybridization was performed as previously described 32 using either a ␣ 32 P-labeled complete HIVcloned in Bluescript previously digested with the same restriction enzymes to obtain the pEDN plasmid. The 1 LW/C LTR (which recognizes all the mRNAs expressed from these constructs and HIV-1) or IRES sequence IRES sequence was amplified from the pLZIN plasmid 31 using Vent DNA polymerase and the oligonucleotide (which hybridizes only with the full-length mRNA transcribed from pBAR-EDN). For dot blot analysis, packprimer pair IRESA/IRESB. After amplification, the PCR product containing the IRES sequence was digested with aged virion RNA was extracted from filtered supernatants of transfected HeLa-Tat cells using TRIzol LS XbaI-SpeI and subcloned into pEDN (see above) previously digested with XbaI to obtain the pIREDN plasreagent (Life Technologies) to which the 7.5 kb RNA (Life Technologies) was added as a tracer to normalize the mid. A NotI linker was then inserted into the EcoRV site of pIREDN to obtain the plasmid pIREDNN. Following amount of RNA from each sample. Following DNase treatment and phenol-chloroform-isoamyl alcohol extracthe digestion of pIREDNN with NotI, the fragment containing the IRES and EDN sequences was inserted into tion, samples were spotted on to a Nytran filter (Schleicher and Schuell). Filters were hybridized with the NotI site of the pBAR plasmid between the delta-gag gene and RRE sequences to obtain the pBAR-EDN plas-␣ 32 P-labeled probes specific for the HIV-1 LTR, the IRES sequence or the HIV-1 envelope (ENV) which detect only mid. For the construction of pBS-BAR-luc, a NotI-BamHI DNA fragment containing the IRES sequence was placed HIV-1 presence but not the protective vectors. Hybridizations with the ampicillin gene (which is present in the in front of the luciferase gene into the NotI-BamHI restriction sites of the pGEM-luc vector (Promega, Madison, plasmid DNA transfected) or DNA (which recognizes the tracer 7.5 kb RNA) were carried out as a negative and WI, USA) to obtain the plasmid pIRES-luc. After digestion of pIRES-luc with EagI, the DNA fragment containpositive control, respectively. Filters were autoradiographed for 48-96 h. ing the IRES-luciferase was subcloned into the NotI site of pBS-BAR to obtain the pBS-BAR-luc plasmid. The control plasmid for luciferase expression 1LTR-luc-LTR-Circle, Western blot analysis Cells were lysed in a solution containing Tris-HCl pH 7.4 and the expression plasmid for Tat, pRBK-Tat, have been previously described. 13 The Rev expression plasmid, 50 mm, NaCl 150 mm, NP40 0.5%, NaF 50 mm, PMSF 1 mm, Na 3 VO 4 1 mm, leupeptine 25 g/ml, aprotinin 25 pRBK-Rev, consists of the Rev gene cloned into the BamHI site of the pRBK plasmid. Transcription of Tat and g/ml and trypsin inhibitor 10 g/ml. Equal amounts of total protein extracts were electrophoresed through a 10% Rev is driven by the RSV promoter.
SDS-PAGE gel, transferred on to nitrocellulose membrane and p55 delta-gag was detected using a rabbit poly-CEM transfection and selection clonal antibody against p24 (Program Resources, NCI, Plasmids pBAR, pBAR-EDN and pRBK were introduced FCRDC, Frederick, MD, USA). Chemiluminescent detecby electroporation into the CEM and Jurkat T cell lines tion of blotted proteins was performed using the ECL kit (10 g of DNA per 2.5 × 10 7 cells, 200 mV, 960 F).
(Amersham, Arlington Heights, IL, USA). Seventy-two hours after transfection, cells were cultured in RPMI medium with 10% fetal calf serum (FCS) and
Cell culture and HIV-1 infection 800 g/ml hygromycin B (Boehringer, Indianapolis, IN, CEM cells were cultured in RPMI 1640 supplemented USA). One month after the selection, more than 95% of with 10% FCS, 2 mm glutamine (complete medium). the transduced cells were CD4 + and showed normal Transduced CEM were maintained in complete medium growth characteristics compared with the parental cell supplemented with 800 g/ml hygromycin B line.
(Boehringer). For infections, cells were incubated with HIV-1 IIIB at an estimated MOI of 2.0, 0.2 and 0.02 tissue culture infectivity dose (TCID) per cell by using a super-DNA transfection The human epithelial HeLa and HeLa-Tat cell lines were natant whose TCID 50 was titrated on H9 cells. In a separate experiment, cells were infected with either the molmaintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). ecular clone HIV-1 NL43 or the primary field isolate HIV-1 BZ167 (kindly provided by D Cohen). After 2 h of incuFor transfection experiments, equimolar amounts of plasmid DNA (up to a total of 30 g), unless differently specibation, cells were washed three times and incubated in tissue culture flasks at a density of 0.5 × 10 6 /ml. Collecfied, were introduced into Hela or HeLa-Tat cells using the calcium phosphate method (ProFection Mammalian tion of the supernatants for viral RT and p24 analysis and cell harvest for DNA analysis, determination of viability Transfection System, Promega). Thirty-six or 48 h after transfections, supernatants were analyzed for RT activity, and expression of cell surface CD4 were carried out twice a week. For RNA analysis, cells were harvested every p24 production and viral RNA. Cell lysates were also other day for the first week after infection and, after-LW/C viral sequence are underlined; the EcoRI site is in bold; sense orientation. wards, once a week.
RT assay and p24 ELISA XDGAS: 5′-GGATCTAGATCTAGATTGCCCCCCTAT-RT assays were performed by standard procedures. Pro-CATTATTGT-3′. The bases corresponding to nt 2284-duction of p24 was analyzed using a p24 antigen capture 2305 in the HXB2 viral sequence are underlined; the XbaI ELISA kit (Coulter, Miami, FL, USA).
sites are in bold; the stop codons are double underlined; antisense orientation. Luciferase assay HeLa cells were transfected using the calcium phosphate SRRES: 5′-GGACGCGTCGACACCATTAGGAGTAmethod with 1 g of the reporter plasmid 1LTR-luc-LTR-GCACCCAC-3′. The bases corresponding to nt 7698-7717 Circle, which contains the firefly luciferase gene between in the HXB2 viral sequence are underlined; the SalI site two complete HIV-1 LW/C LTR, 13 or pBS-BAR-luc (see is in bold; sense orientation. Expression vectors). The pGEM-luc (Promega) containing the luciferase gene without any promoter was used to BLU5AS: 5′-CGCGGATCCACTGACTAAAAGGGTCTmeasure the background activity. The control plasmid GAG-3′. The bases corresponding to nt 9681-9700 in the pRBK or pRBK-Rev and pRBK-Tat plasmids were HXB2 viral sequence are underlined; the BamHI site is in cotransfected into the indicated cells along with each bold; antisense orientation. reporter construct in a 2:1 molar ratio. Forty-eight hours after transfection cells were lysed in a solution containing ENVA: 5′-AGAAATATCAGCACTTGTGGAGA-3′. The 1% Triton X-100, 2 mm DTT, 25 mm Tris-Cl pH 7.8, 2 sequence corresponds to nt 6237-6259 in the HXB2 viral mm CDTA, and 10% glycerol and analyzed for luciferase sequence; sense orientation. activity using a Berthold luminometer.
PCR analysis
ENVB: 5′-TGAGTGGCCCAAACATTATGTACCT-3′. The DNA was extracted using the urea lysis method. Briefly, sequence corresponds to nt 6414-6438 in the HXB2 viral cells were lysed in a solution containing 7 m urea, 0.3 m sequence; antisense orientation. NaCl, 10 mm Tris-Cl pH 8.0, 10 mm EDTA pH 8.0 and 1% SDS and incubated at 65°C for 1 h. Samples were phenol-ENVC: 5′-CACCACTCTATTTTGTGCATCAGATG-3. The chloroform extracted and resuspended in water after two sequence corresponds to nt 6369-6395 in the HXB2 viral 70% ethanol washes. PCR amplification was performed sequence; sense orientation. depending on the primer pair used. Primers ␤GS/␤GAS and conditions used for amplification of ␤-globin have IRESA: 5′-GCTCTAGAGGAATTCCGCCCCTC-3′. The been described. 33 After normalization, 10 ng of DNA and XbaI site is in bold; the EcoRI site is underlined; sense primers ENVA/ENVB were used to amplify the envelorientation (5′ of the sequence). ope (env) region of HIV-1. The conditions for amplification were: 1 min at 94°C (denaturation), 1 min at 60°C
IRESB: 5′-GACTAGTGGCAAGCTTATCATCGTG-3′; (annealing) and 1 min at 72°C (extension) for 30 cycles.
The SpeI site is in bold; antisense orientation (3′ of the For detection of the amplified envelope fragments, sequence). primer ENVC was used after T4 ␣ 32 P end-labeling. Primers 516/477 were used to amplify the 2-LTR circular form of HIV-1 in the region spanning the junction EDN␣: 5′-CGCGGATCCTTGATATGCTGAGTTTCGAbetween the two LTRs (U5-U3) for 40 cycles as ACCA-3′. Sense orientation. described 29 using 20 ng of DNA. The probe was oligonucleotide 569F. For the standard curve (stds DNA), serial EDN: 5′-AAGGAAAAAAGCGGCCGCCTACTAGATdilutions of a plasmid containing the same region of GATACGGTCCAGA-3′. Antisense orientation. DNA to be amplified were used. As external controls for ␤-globin amplification, serial dilutions of known amounts Oligonucleotides 516, 477, 569F, ␤GS and ␤GAS were of genomic DNA were used. All PCR products were blotpreviously described.
29 ted on to 0.2 m pore size Nytran membranes (Schleicher and Schuell) and analyzed using standard methods. 
